David Asch, M.D., MBA, has been named Executive Director of the Leonard Davis Institute of Health Economics, Penn's health-care think tank, where he will be responsible for the continuation and expansion of the Institute's research on financing and management of the nation's health care system. He will also serve as Robert D. Eilers Associate Professor of Medicine and Health Care Management and Economics and the School of Medicine and the Wharton School.
Richard Salcido, M.D., has been appointed Chairman of the Department of Rehabilitation Medicine at the Health System, effective Sept. 1. He had been an Associate Professor and Chair of the Department of Physical Medicine at the University of Kentucky School of Medicine. Salcido plans to increase the influence of rehabilitation medicine throughout Penn Medicine's programs.
Mark L. Tykocinski, M.D., has been apponted Chairman of the Department of Pathology and Laboratory Medicine at the Health System, effective Sept. 1. Tykocinski, who was a Professor of Pathology at Case Western Reserve University, plans to continue with establishing Penn as a world-renowned facility in the field.
Jill Beech (V'72), D.V.M., has been named University Judicial Administrator, the person who presides over all student disciplinary and academic integrity hearings. Beech, professor of medicine in the School of Veterinary Medicine, is chief of the section of large animal medicine and reproduction at New Bolton Center.
Joan Burritt, DNSc, RN, has been named Chief Nursing Officer and Associate Hospital Administrator at the Hospital of the University of Pennsylvania. She was Director of Medical Nursing and Interim Director of Ambulatory Nursing at Yale-New Haven Hospital in Connecticut. Her responsibilities include enhancing clinical effectiveness and developing innovative, cost-effective ways to promote seamless delivery of high quality, compassionate care to patients.
“More companies are asking how they can separate themselves from the organization and instead tighten their connection to the game. The brand of FIFA is problematic but the game of soccer is still popular.”
— Kenneth L. Shropshire, director of the Wharton Sports Business Initiative, on how the FIFA corruption scandal has caused some sponsors to be less concerned about partnering with the powerful soccer organization. FIFA tends to have the most leverage when negotiating deals with companies, but experts are wondering whether sponsors will be able to demand clauses that allow them to leave in cases of corruption. (The Los Angeles Times, June 3, 2015)